Read our latest advice on Coronavirus (COVID-19)

Our services are open and safe to attend – we are here to help

Xeroderma pigmentosum (XP) service



Coronavirus: dermatology update

In response to the coronavirus (COVID-19) outbreak, please read our advice and information.


XP patient Alex Webb wears a visor when outdoors to protect against UV light

Xeroderma pigmentosum (XP) is a rare, hereditary skin disorder affecting 1 in 250,000 people.

People with xeroderma pigmentosum are not able to repair the damage caused to their skin by the ultraviolet (UV) part of daylight. They can burn easily or develop abnormal freckles on skin that is exposed to UV. They can also develop eye, nerve or brain problems, and are more likely to develop skin cancers, especially if they do not protect their skin from the harmful effects of UV.

We are the only designated national service for xeroderma pigmentosum. We diagnose and treat adults and children from across the UK, working closely with our specialists in photodermatology, the dermatology surgery and laser unit, children's neurology, genetics, ophthalmology (eye), psychology and the neurogenetics department at University College Hospital.

Our patients see a wide range of health professionals at our clinic including dermatology specialists. Our specialist nurses visit patients at their home, school or workplace.

Join our online community

Follow the Xeroderma Pigmentosum UK community on HealthUnlocked, the social network for health.

Our research

Find out more about our xeroderma pigementosum research.

SKIN, a history

Read more about xeroderma pigmentosum in SKIN, a history using our page turning software or download chapter 3 (PDF 3.14Mb).